INTEGRAL MOLECULAR INC - TO DISCOVER AND CHARACTERIZE B CELL EPITOPES AGAINST THE VIRAL PATHOGENS RVFV, CCHFV, AND EV-D68.

PIID: 75N93024C00071Solicitation ID: BAA-NIAID-75N93023R00002

Signed Date: Sep 11, 2024Effective Date: Sep 16, 2024End Date: Closes in 368 days

Award $

$4.9M

Vendor

INTEGRAL MOLECULAR INC

NAICS

541715

Signed Date

Sep 11, 2024

Key Details

Dollars Obligated

$4.9M

Base & All Options

$8.1M

Awarding Agency

Department of Health and Human Services

Awarding Sub-Agency

National Institutes of Health

NAICS Code

541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)

Product Service Code

AN12 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

Place of Performance

PHILADELPHIA, PA

Description

TO DISCOVER AND CHARACTERIZE B CELL EPITOPES AGAINST THE VIRAL PATHOGENS RVFV, CCHFV, AND EV-D68.

Context & Analysis

On Sep 11, 2024, Department of Health and Human Services obligated $4,866,955 to INTEGRAL MOLECULAR INC for to discover and characterize b cell epitopes against the viral pathogens rvfv, cchfv, and ev-d68.. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY). Competition extent: full and open competition with 18 offers received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in PHILADELPHIA, PA. The contract is scheduled through Sep 15, 2027 — approximately 12 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.